Moderna got the FDA to change its mind and review its flu vaccine after some concessions
ModernaModerna(US:MRNA) MarketWatch·2026-02-18 23:22

公司事件与股价反应 - Moderna公司股价在FDA宣布将审查其流感疫苗候选产品后大幅上涨 [1] - FDA的审查决定发生在其一周前拒绝审查之后 [1] 监管进展 - 美国食品药品监督管理局FDA将审查Moderna公司的流感疫苗候选产品 [1]

Moderna got the FDA to change its mind and review its flu vaccine after some concessions - Reportify